Voyageur Pharmaceuticals (CVE:VM) Trading 14.3% Higher – Should You Buy?

Voyageur Pharmaceuticals Ltd. (CVE:VM)’s stock price shot up 14.3% during trading on Tuesday . The stock traded as high as C$0.24 and last traded at C$0.24. 450,853 shares changed hands during trading, a decline of 2% from the average session volume of 458,386 shares. The stock had previously closed at C$0.21.

Voyageur Pharmaceuticals Price Performance

The firm has a market capitalization of C$33.47 million, a P/E ratio of -24.00 and a beta of 0.32. The company has a fifty day moving average of C$0.10 and a 200 day moving average of C$0.07. The company has a debt-to-equity ratio of 3.21, a current ratio of 0.17 and a quick ratio of 0.84.

Voyageur Pharmaceuticals Company Profile

Voyageur Pharmaceuticals Ltd., together with its subsidiaries, engages in the acquiring, exploring, and developing raw materials for pharmaceutical products, primarily in the province of British Columbia, Canada, and the state of Utah. The company develops barium and iodine-based APIs. The company was formerly known as Voyageur Minerals Ltd.